A story in U.K. newspaper The Telegraph says Johnson & Johnson employees were not only aware of problems with its ASR hip implant for years before the device’s 2010 recall, but actively discussed manipulating data to conceal those problems.
Studies show that nearly half of the implants, made by Johnson & Johnson subsidiary DePuy Orthopaedics, break down and need replacement after only a few years. They also have a tendency to ...
continue reading...
An editorial in the New York Times takes Johnson & Johnson subsidiary DePuy Orthopaedics to task for apparently sitting on evidence that a line of its hip implants posed a danger to patients.
“Though the company says the evidence will ultimately show that it acted appropriately, it clearly has a lot of explaining to do,” the editorial says.
The model in question ...
continue reading...
During a trial centering on Johnson & Johnson’s ASR hip implants, Bloomberg reports, a biomedical engineering expert told the jury that the devices had multiple design flaws.
Johnson & Johnson recalled the all-metal implants, manufactured by subsidiary DePuy Orthopaedics, in 2010. At the time, the company said 12 percent fail within five years. Subsequent studies found that nearly half of them ...
continue reading...
A piece in The Economist deals with the negative information coming out in Johnson & Johnson’s trial over ASR hip implants manufactured by its subsidiary, DePuy Orthopaedics.
“Most companies do everything they can to keep their executives away from court,” the piece states. “A case in California helps to demonstrate why.”
Studies have shown nearly half of the implants break down and ...
continue reading...
In a bipartisan effort, U.S. Senators have reintroduced legislation banning a pharmaceutical industry practice that keeps lower-cost medications away from patients who need them. The practice, commonly called “pay for delay,” occurs when one drug company pays another to delay introducing a less-expensive generic version of a medication.
According to Reuters, both American and European anti-trust regulators have long criticized the practice. It recently came to the forefront again after European ...
continue reading...
In a Los Angeles Superior Court trial, an occupational medicine specialist testified that a man’s artificial hip had to be removed because of “toxic exposure” from metal debris that the implant was shedding, according to a Reuters story.
Plaintiff Loren Kransky’s is the first of more than 10,000 U.S. lawsuits about the implants to go to trial.
The artificial hips, made by Johnson & Johnson subsidiary DePuy Orthopedics, feature both a ball ...
continue reading...
